Lytix Biopharma AS

OB:LYTIX Stock Report

Market Cap: NOK 355.0m

Lytix Biopharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OB:LYTIX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
16 Dec 24BuyNOK 81,000Kjetil HestdalIndividual13,500NOK 6.00
16 Dec 24BuyNOK 99,996Oystein RekdalIndividual16,666NOK 6.00
16 Dec 24BuyNOK 19,000,001Saturn Invest ASCompany3,166,666NOK 6.00
16 Dec 24BuyNOK 49,998Baldur SveinbjørnssonIndividual8,333NOK 6.00
16 Dec 24BuyNOK 99,996Gjest BreisteinIndividual16,666NOK 6.00
16 Dec 24BuyNOK 25,644Evelina VagesjoIndividual4,274NOK 6.00

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of LYTIX?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders17,7470.026%
Institutions7,953,93211.7%
General Public26,257,33838.5%
Private Companies34,032,98549.9%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 70.4%.

Top Shareholders

Top 22 shareholders own 61.53% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.93%
Jakob Hatteland Holding AS
6,095,482NOK 31.7m37.6%no data
7.17%
Citigroup Inc.,Banking and Securities Investments
4,896,422NOK 25.5m3.93%no data
6.57%
Saturn Invest AS
4,485,579NOK 23.3m240%no data
6.53%
Taj Holding As
4,455,566NOK 23.2m59.8%no data
3.66%
Skandinaviska Enskilda Banken AB, Asset Management Arm
2,500,000NOK 13.0m274%0.18%
3.57%
Lyr Invest As
2,438,863NOK 12.7m0%no data
3.35%
BrøDrene Karlsen Holding A/S
2,283,507NOK 11.9m33.6%no data
2.96%
Per Strand Eiendom As
2,019,102NOK 10.5m33.6%no data
2.65%
3T Produkter Holding AS
1,808,764NOK 9.4m0%no data
2.12%
Lysnes Invest As
1,448,987NOK 7.5m135%no data
2.04%
Ynni Invest As
1,392,889NOK 7.2m0%no data
1.93%
Hifo Invest AS
1,318,913NOK 6.9m0%no data
1.92%
Kvasshøgdi AS
1,307,652NOK 6.8m46.8%no data
1.47%
Care Holding As
1,006,512NOK 5.2m-1.74%no data
1.4%
Belvedere AS
955,027NOK 5.0m25.6%no data
1.31%
Lth Invest As
896,786NOK 4.7m0%no data
1.08%
Jahatt AS
738,167NOK 3.8m0%no data
1.02%
Picasso AS
695,753NOK 3.6m0%no data
1%
Dragesund Invest AS
685,436NOK 3.6m39.7%no data
0.82%
Norinnova Invest AS
557,510NOK 2.9m0%no data
0.02%
Kjetil Hestdal
13,500NOK 70.2k0%no data
0.0062%
Evelina Vagesjo
4,247NOK 22.1k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/25 08:13
End of Day Share Price 2025/03/25 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Lytix Biopharma AS is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Carl RamaniusRedeye